Vivia Biotech

VIVIA BIOTECH.png

Contact information

Vivia Biotech, SL
Andrés Ballesteros, Directot General
C/ Severo Ochoa 35 Edif Bioanand
Campanillas
Malaga
952367628
983440787
Areas of activity
  • A. Health Biotechnology
  • A. Health Biotechnology
  • Therapeutic areas
  • A. Health Biotechnology
  • Therapeutic areas
  • Cardiovascular diseases and circulatory system
  • A. Health Biotechnology
  • Therapeutic areas
  • Genetic and rare diseases
  • A. Health Biotechnology
  • Therapeutic areas
  • Immunology
  • A. Health Biotechnology
  • Therapeutic areas
  • Oncology
  • A. Health Biotechnology
  • Therapeutic areas
  • Blood and lymphatic system
  • A. Health Biotechnology
  • Therapeutic areas
  • Metabolic disorders / Endocrinology
  • A. Health Biotechnology
  • Areas of activity
  • A. Health Biotechnology
  • Areas of activity
  • In vitro diagnostics
  • A. Health Biotechnology
  • Areas of activity
  • Screening

Vivia Biotech pioneers the screening of thousands of drugs directly in patient´s blood samples,an innovative Systems Biology research model, really translational, which has allowed implementing for the first time in the world the Exvitech Tecnological Platform, property of Vivia Biotech.

Products and services

Vivia Biotech is a worldwide pioneer in screening thousands of drugs or combinations in a patient sample through its proprietary ExviTech© technology platform.

Vivia has developed and clinically validated a Personalized Medicine Test for Hematological Cancers that identifies the best available drug combination treatment for each individual patient. The test discriminates between sensible and resistant protocol treatments for each patient, and uses gold standard diagnostic equipment (flow cytometry), adding automation and data mining capabilities.

Smart Reprofiling : by analyzing thousands of drugs on a patient's sample, we identify potentially effective drugs for a disease in the most direct way which, until now, was not possible.